Navigation Links
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
Date:7/29/2009

DALLAS, July 29 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), announced today that it is evaluating strategic options for the commercialization of MuGard in North America. MuGard is an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy, and previously announced data suggest that the market for MuGard is significantly greater than previously expected. Frank Jacobucci, formerly President & CEO of Milestone Biosciences, has joined Access as a consultant, and will assist with ongoing reimbursement, manufacturing and commercial launch activities at Access, while discussions with potential licensee and co-promotion partners is ongoing.

"Access is focused on maximizing the potential of MuGard, both for patients and for its shareholders," states Jeffrey B. Davis, Access' President & CEO. "Bringing MuGard back in-house will enable Access to capture more of MuGard's value for shareholders, and be more intimately involved in the ongoing commercialization activities. I welcome the expert insight and experience of Frank Jacobucci, who brings great knowledge and expertise in launching pharma products, with a particular expertise in oral mucositis and related indications, and of course MuGard."

Mr. Jacobucci has over 20 years experience in sales management, including senior sales executive positions at oncology focused companies including MGI Pharma, Genetics Institute, Wyeth Oncology, Aventis, Precision Therapeutics and CRC Oncology Services.

"I have always known the substantial potential for MuGard in the prevention and treatment of oral mucositis as well as it being very important for the medical community, and an exciting commercial opportunity in the pharma sector," stated Frank Jacobucci. "I look forwa
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. The State of Louisiana and Together Rx Access Join Forces to Improve Prescription Access for Uninsured Residents
2. Fingertip Formulary Accounts(R) Now Offers Access to Comprehensive Real-Time Account Information and Integrated Formulary Data, in a State-of-the Art Web-Based Platform
3. Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
4. Cold Laser Technology Made Even More Accessible with Powerful New Product Available from Laser-Therapy.US
5. Accuray Announces CyberKnife Access Remote Service Product
6. President Obama Announces Intention to Sign United Nations Convention on the Rights of Persons with Disabilities, Impacts Accessible ICT
7. Cost-Conscious Texans Find Relief with Direct Access Lab Testing
8. UPDATE: Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
9. Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
10. Access Pharmaceuticals to Present at Jessup & Lamont 2009 Growth Stock Conference
11. Carefx Implements Fusionfx at Fletcher Allen Health Care to Improve Anywhere/Anytime Access to Crucial Patient Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... York, New York (PRWEB) September 21, 2014 ... ) continue to move forward in Pennsylvania’s Philadelphia ... According to court documents, the proceeding’s next monthly ... (Risperdal Litigation, case number 100300296) , “Our Firm ... filed Risperdal lawsuits in this litigation. We are ...
(Date:9/21/2014)... Best Cheap Hosting USA, one of the ... and GreenGeeks are the best Reseller hosting suppliers in ... hosting supplier. Actually, these companies have outperformed their competitors ... People can get the best web hosting at affordable ... to the manager, reseller hosting is a very popular ...
(Date:9/21/2014)... TX (PRWEB) September 21, 2014 ... Chinese Fenofibrate (CAS 49562-28-9) Industry, 2009-2019 is ... Global and Chinese Fenofibrate (CAS 49562-28-9) industry. ... of Fenofibrate (CAS 49562-28-9) including its classification, ... global and China’s top manufacturers of Fenofibrate ...
(Date:9/21/2014)... September 21, 2014 More than ... been added over the past month to a ... serious cardiovascular injuries caused by the dialysis concentrate, ... updated on September 15th shows 2,089 cases filed ... District Court, District of Massachusetts. These claims were ...
(Date:9/21/2014)... BambooIndustry.com, an experienced producer of natural bamboo items, has ... http://www.bambooindustry.com/products/bamboo-panel/ ). The company’s excellent panels are very popular ... discounted prices now, from 10 to 30 percent off. ... are available in many specifications; they are promised to ... finely manufactured by qualified workers. They are specially offered ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 4Health News:Best Cheap Hosting USA Announces The Best Reseller Hosting Suppliers In 2014 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4Health News:Discounted Bamboo Panels For Sale At BambooIndustry.com 2
... Inc.,(NYSE: ZMH ; SWX: ZMH), a leader in the ... upcoming investor,conferences: -- November 27, 2007 -- 19th Annual ... York, New York, 9:00 a.m. Eastern Time -- December ... York, New York, 9:30 a.m. Eastern ...
... -- China Medical,Technologies Inc. (the "Company") (Nasdaq: ... company that develops, manufactures and markets advanced ... focused ultrasound tumor,therapy systems, today announces the ... and Dr. Yuedong Li as member for ...
... SALEM, Mass., Nov. 19 LaVoie Group, a ... today announced,that it has been selected as agency ... The GI Company, of Framingham, MA. Donna ... engaged in,providing strategic communications counsel and tactical execution ...
... Support for True Wealth Measures: Three-Quarters Say Governments, ... Environmental Progress, BRUSSELS, Belgium, Nov. 19 ... should look beyond,economics, and include health, social and ... believe that economic growth,alone is the most important ...
... November 19 ThalesNano Inc.,and the Christian ... Karl-Franzens-University in Graz today announced a scientific,collaboration ... focus,on the application of flow reactors for ... utilizing ThalesNano,s background in,continuous processing. ThalesNano and ...
... a dollar value has been attached to the high cost ... that reveals a massive annual cost of $34.3 billion -- ... grappling with pain. The price tag of pain includes ... MBF Foundation study The High Price of Pain: The Economic ...
Cached Medicine News:Health News:China Medical Technologies Announces Changes in Board of Directors and Appointment of Chief Technology Officer 2Health News:China Medical Technologies Announces Changes in Board of Directors and Appointment of Chief Technology Officer 3Health News:LaVoie Group Adds Two New Companies to Its Life Science Client Roster 2Health News:GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th 2Health News:GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th 3Health News:ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies 2Health News:ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies 3Health News:First study of Australia's high cost of pain reveals $34 billion price tag 2
(Date:9/19/2014)... -- UBM Medica US announces that  OncoTherapy ... oncologists and other clinicians gain a better understanding of ... therapies and immunotherapies, discusses some of the latest news ... Every September, Blood Cancer Awareness Month is ... cancers—helping to increase survival rates and improve the quality ...
(Date:9/19/2014)... , Sept. 19, 2014 Larry J. Merlo ... CVS ), will speak before the National Press Club in ... the company,s recent move to stop selling tobacco products and ... future of health. "Dramatic changes in our health ... providers and government," Merlo has said. "CVS Health has a ...
(Date:9/19/2014)...  Alere Inc. (NYSE: ALR ), a ... today in support of President Barack Obama,s ... global leader in rapid diagnostics for infectious disease, we ... address the serious threat of antibiotic resistance. We look ... initiatives to promote the development of rapid point-of-care tests ...
Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2
... Inc. and Norgenix Pharmaceuticals, LLC today announced an agreement ... well as US territories and military bases for Femasys, ... to evaluate a woman,s fallopian tubes with standard ultrasound, ... medical device developer of women,s healthcare solutions. Norgenix Pharmaceuticals, ...
... /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or ... the largest network of radiotherapy and diagnostic imaging centers in ... ADS for its unaudited consolidated financial results for the second ... ended June 30, 2010. Second ...
Cached Medicine Technology:Femasys and Norgenix Announce Distribution Agreement for Groundbreaking New Device for Infertility Diagnosis 2Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 2Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 3Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 4Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 5Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 6Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 7Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 8Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 9Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 10Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 11Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 12
... & Transfer System is a patent-pending disposable, ... procedures simpler for the physician and their ... an office-based technique. LipiVage™ improves upon traditional ... a need to centrifuge, decant or expose ...
... Type B) Injectable Solution, the only Botulinum ... demonstrated in numerous published studies to be ... Delivered as a purified, ready-to-use solution, ... a simpler way to significantly reduce abnormal ...
... is a simple, nonsurgical, physician-administered treatment that ... lines between the brows in people from ... is the only treatment of its type ... (FDA). BOTOX® Cosmetic is a purified ...
Inquire...
Medicine Products: